[HTML] from nih.govO Finco, E Frigimelica, F Buricchi… - Proceedings of the …, 2011 - National Acad Sciences Natural immunity against obligate and/or facultative intracellular pathogens is usually mediated by both humoral and cellular immunity. The identification of those antigens stimulating both arms of the immune system is instrumental for vaccine discovery. Although high-throughput ... Related articles - All 4 versions
B Chellas-Gery, K Wolf, J Tisoncik… - Infection and …, 2011 - Am Soc Microbiol 1 2 3 Biochemical and localization analyses of putative type III secretion translocator 4 5 proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions 6 7 8 B. Chellas-Géry1, K. Wolf1, J. Tisoncik2, T. Hackstadt3, and KA Fields1* 9 10 11 12 ... All 2 versions
SG Morrison, CM Farris… - Journal of Infectious …, 2011 - jid.oxfordjournals.org Chlamydia muridarum and Chlamydia trachomatis mouse models of genital infection have been used to study chlamydial immunity and vaccine development. To assess the protective role of CD4 + T cells in resolving C. trachomatis and C. muridarum genital tract infections, we ... Cited by 2 - Related articles - All 5 versions
[HTML] from nih.govL Kari, MM Goheen, LB Randall… - Proceedings of the …, 2011 - National Acad Sciences Chlamydia trachomatis is an obligate intracellular bacterial pathogen that infects hundreds of millions of individuals globally, causing blinding trachoma and sexually transmitted disease. More effective chlamydial control measures are needed, but progress toward this end has ... Cited by 2 - Related articles - All 4 versions
CM O'Connell, YM AbdelRahman… - Infection and …, 2011 - Am Soc Microbiol Page 1. 1 Title: TLR2 activation by Chlamydiatrachomatis is plasmid-dependent and plasmid- 1 ... Thus, additional plasmid-associated factors are required for 33 glycogen accumulation by this chlamydial species. Furthermore, in C. trachomatis, glgA and other 34 ... Cited by 2 - Related articles - All 2 versions